- Home
- CELC vs BBUC Comparison
CELC vs BBUC Comparison
Compare CELC & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- BBUC
- Stock Information
- Founded
- CELC 2011
- BBUC 2022
- Country
- CELC United States
- BBUC United States
- Employees
- CELC N/A
- BBUC N/A
- Industry
- CELC Medical Specialities
- BBUC
- Sector
- CELC Health Care
- BBUC
- Exchange
- CELC Nasdaq
- BBUC Nasdaq
- Market Cap
- CELC 2.3B
- BBUC 2.4B
- IPO Year
- CELC 2017
- BBUC N/A
- Fundamental
- Price
- CELC $51.88
- BBUC $35.69
- Analyst Decision
- CELC Strong Buy
- BBUC
- Analyst Count
- CELC 5
- BBUC 0
- Target Price
- CELC $67.20
- BBUC N/A
- AVG Volume (30 Days)
- CELC 1.1M
- BBUC 198.1K
- Earning Date
- CELC 11-13-2025
- BBUC 11-06-2025
- Dividend Yield
- CELC N/A
- BBUC 0.68%
- EPS Growth
- CELC N/A
- BBUC N/A
- EPS
- CELC N/A
- BBUC N/A
- Revenue
- CELC N/A
- BBUC $8,240,000,000.00
- Revenue This Year
- CELC N/A
- BBUC N/A
- Revenue Next Year
- CELC N/A
- BBUC N/A
- P/E Ratio
- CELC N/A
- BBUC N/A
- Revenue Growth
- CELC N/A
- BBUC 6.96
- 52 Week Low
- CELC $7.58
- BBUC $21.52
- 52 Week High
- CELC $63.06
- BBUC $37.89
- Technical
- Relative Strength Index (RSI)
- CELC 53.91
- BBUC 55.33
- Support Level
- CELC $45.15
- BBUC $33.31
- Resistance Level
- CELC $50.00
- BBUC $37.89
- Average True Range (ATR)
- CELC 3.48
- BBUC 1.33
- MACD
- CELC -0.04
- BBUC 0.18
- Stochastic Oscillator
- CELC 64.67
- BBUC 60.25
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.